Why Biopharma is Prioritizing Data to Build Better Medicines
We spoke with 500 biopharma executives to discover how industry leaders plan to deliver better therapeutics to patients faster. Their answer was clear. Maximize the value of scientific data with cloud-enabled FAIR data to improve three key industry drivers.
- Speed: Learning from experiments faster, reducing time-to-market for final molecules
- Cost: Improving productivity, increasing operational efficiency, increasing return on investment (ROI)
- Risk: Improving safety, reducing errors, improving compliance with regulatory requirements
Explore our key findings by downloading this infographic or see the full research report.